EGFR-TKI resistance due to BIM polymorphism can be circumvented in combination with HDAC inhibition.

By T. Nakagawa, S. Takeuchi, Tadaaki Yamada, H. Ebi, Takako Sano, S. Nanjo, Daisuke Ishikawa, Mitsuo Sato, Y. Hasegawa, Y. Sekido and 1 more. Cancer Research, 2013

702 citations recorded by the source corpus.

Subfields: Molecular Biology, Oncology, Organic Chemistry

View Paper: https://www.semanticscholar.org/paper/debf9a05deb9a1d7992a92a16aa476ba5bd4a2bf